Abstract Aims-To study the effect of proctocolectomy on the antineutrophil cytoplasmic antibody (ANCA) titres in association with ulcerative colitis. Methods-Serum samples were taken from 15 patients with ulcerative colitis immediately before and at a mean of 24 months after proctocolectomy. Indirect immunofluorescence for ANCA and enzyme immunoassays for myeloperoxidase and proteinase-3 antibodies were employed. A liver biopsy was taken from every patient during the proctocolectomy, and serum liver enzyme activities were also determined. Results-Before proctocolectomy, 13 of the 15 patients had perinuclear antineutrophil cytoplasmic antibodies (p-ANCA). Additionally, one patient had a low titre of classical cytoplasmic ANCA and one had granulocyte specific antinuclear antibodies. After proctocolectomy, the ANCA titres decreased in 10 patients, in two ofwhom they became negative. The titres remained the same in four patients with positive ANCA and increased twofold in one patient. Only one patient was proteinase-3 antibody positive and all 15 patients were myeloperoxidase antibody negative. The clinical condition improved in all patients, irrespective of the ANCA status after proctocolectomy. Seven patients, all of whom were positive for p-ANCA before proctocolectomy, had histological liver abnormalities. No correlation was observed between serum liver enzyme levels and ANCA staining patterns or titres.
An association with antineutrophil cytoplasmic antibodies (ANCA) has been established in a variety of primary vasculitic syndromes' and more recently with inflammatory bowel disease.23 Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA), the predominant immunofluorescence pattern in inflammatory bowel disease, have been detected in up to 84% of sera of patients with ulcerative colitis, differentiating it from Crohn's disease and other colitides.23 In contrast to vasculitides, especially Wegener's granulomatosis, where a correlation between disease activity and ANCA has been shown,4 most studies have not found a correlation between ANCA and the clinical activity or extent of ulcerative colitis. 2 7 Whether ANCA in ulcerative colitis is merely an epiphenomenon related to colonic mucosal inflammation or reflects disturbances in immune regulation is still unclear.
Patients with ulcerative colitis may have extraintestinal manifestations, of which liver abnormalities are the most frequent. Primary sclerosing cholangitis has been shown to occur in 3-7% of patients with ulcerative colitis,8 and about 70% of patients with primary sclerosing cholangitis have concomitant ulcerative colitis. The aetiology and pathogenesis of these two conditions are still unknown, although autoimmune mechanisms are suspected. The detection ofp-ANCA in over 80% ofboth diseases suggests a shared immunopathogenic mechanism between these diseases.79
Proctocolectomy has been successfully used in the surgical treatment of ulcerative colitis. However, reports on the effect of proctocolectomy on ANCA in ulcerative colitis are controversial. Positive p-ANCA has also been detected in ulcerative colitis patients after colectomy. 236910
In the present study we investigated the effect of proctocolectomy on the ANCA titres in patients with ulcerative colitis. In view of the close relationship of ulcerative colitis and liver abnormalities, the association of ANCA with liver biopsy findings in these patients was also addressed.
Methods
The study population consisted of 15 months) after the operation. Specimens were stored at -20°C until analysed. Serum ANCA patterns and titres and serum liver enzyme levels (alkaline phosphatase, normal range 60-275 U/l, and alanine aminotransferase, normal range <40 U/1) were determined. Liver biopsy was taken during the proctocolectomy. All liver biopsies were reviewed and classified by one pathologist according to Ludwig et al. " 2 Indirect immunofluorescence employing ethanol and formalin fixed human granulocytes was used as a standard method'314 to detect ANCA. Different staining patterns ofANCAthat is, classical diffuse cytoplasmic ANCA (c-ANCA), perinuclear ANCA (p-ANCA), and granulocyte specific antinuclear antibodies (GS-ANA)-were identified as described. '5 The indirect immunofluorescence analyses were performed in a single run, and the analyst was blinded to the clinical data and the sequence of the specimens taken. Commercially available kits based on enzyme immunoassay were used for the analysis of myeloperoxidase antibodies and proteinase-3 (PR-3/ANCA) antibodies of IgG isotype (Ferring Diagnostica). Both kits were used according to manufacturer's instructions. A serum dilution of 1:76 was used in both assays. Values exceeding that of the lowest standard (10EU) were regarded as positive.
The study was approved by the ethics committee of Tampere University Hospital.
For statistical analysis, the Wilcoxon signed rank test and the Kruskal-Wallis analysis of variance were employed. The changes in ANCA titres after proctocolectomy are shown in the figure. In nine of the 13 patients positive for p-ANCA, the titres decreased; in two of these they turned negative. In three patients the titres remained the same. In one patient only a twofold higher p-ANCA titre was observed 22 months after proctocolectomy. The mean p-ANCA titres were significantly lower after proctocolectomy than before it (p<0Q0069). Also in the patient with positive GS-ANA before proctocolectomy the titre decreased after the operation. In the patient with a low titre of c-ANCA preoperatively the titre remained the same after proctocolectomy. The clinical condition improved in all patients, irrespective ofthe ANCA status after proctocolectomy.
Six patients had normal histology at liver biopsy, two had mild steatosis, four had nonspecific reactive hepatitis, and three had fibrous non-suppurative cholangitis (one stage I, one stage II with primary sclerosing cholangitis proven by cholangiography, and one stage III). All patients with fibrous cholangitis or nonspecific reactive hepatitis at liver biopsy were positive for p-ANCA. No significant difference in ANCA titres was observed between patients with different liver biopsy findings. No correlation was found between ANCA titres and serum liver enzyme levels (data not shown). Follow up liver enzyme values showed no signs of worsening of the liver function in any of the patients after proctocolectomy.
Discussion
The three main staining patterns of ANCA, namely c-ANCA, p-ANCA, and GS-ANA, are detected with different disease associations. '6 The predominant staining pattern in ulcerative colitis and primary sclerosing cholangitis has been shown to be atypical p-ANCA, which has been found in up to 84% of patients with ulcerative colitis. compared to 34% of 32 ulcerative colitis patients with prior proctocolectomy. In contrast, Rump et al7 have suggested that a correlation exists between disease activity and p-ANCA titre in ulcerative colitis. Furthermore, they have reported two patients with ulcerative colitis who became negative for ANCA after proctocolectomy.
In our study, 15 patients were examined for the presence of ANCA before and after proctocolectomy. Two patients initially positive for ANCA became negative and eight showed lower ANCA titres after proctocolectomy. Thus proctocolectomy decreased the ANCA activity significantly in most of our patients. The decline in ANCA titres after proctocolectomy suggests that by reducing inflammation or the available antigenic material proctocolectomy modifies the activity of the immune disturbance related to ulcerative colitis.
In most studies on ulcerative colitis, in which testing for specific ANCA associated antigens has been carried out, no significant reactivity with proteinase-3 or myeloperoxidase has been detected.2518 In a recent study, Ellerbroek et al reported that 22% of ulcerative colitis patients positive for p-ANCA recognised lactoferrin and 19-5% cathepsin G. However, p-ANCA occurring in inflammatory bowel disease still has an undefined major target antigen.19 This is in accordance with our study, as we tested all patients' sera both pre-and postoperatively by enzyme immunoassay for myeloperoxidase and proteinase-3 antibodies and found that all patients were myeloperoxidase antibody negative and only one patient was proteinase-3 antibody positive. While it is unusual to see proteinase-3 antibodies manifest as p-ANCA, it remains possible that a non-specific antibody reaction was causing even this finding. In fact, serum antibodies to dietary agents such as cow's milk proteins that are widely used as blocking agents in enzyme immunoassays are not unusual in ulcerative colitis. 20 Duerr et alP suggested that the presence or absence of ANCA could be used to distinguish between primary sclerosing cholangitis and other chronic hepatobiliary inflammatory diseases. However, p-ANCA has been reported to occur with other hepatobiliary diseases, for example autoimmune hepatitis and non-A, non-B, non-C hepatitis, although the prevalence is lower than that in primary sclerosing cholangitis.7 No correlation between ANCA and histological stage of primary sclerosing cholangitis or liver function values in patients with this condition has been found.921 22 In our study, all three patients with fibrous cholangitis (one with primary sclerosing cholangitis proven by cholangiography, two with liver histology consistent with small duct primary sclerosing cholangitis) and all patients with non-specific reactive hepatitis at liver biopsy at proctocolectomy were positive for p-ANCA. However, ANCA were also detected among patients with normlal liver histology.
Our study supports earlier findings in showing a high prevalence of ANCA in ulcerative colitis. After proctocolectomy the ANCA titres decreased in the majority of our patients, suggesting that reduction of the inflammation or the available antigenic material modifies the immune disturbance related to ulcerative colitis. Whether ANCA can be used to indicate the disease activity of ulcerative colitis in relation to therapeutic measures other than proctocolectomy requires further study.
